Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93.1M
-
Number of holders
-
242
-
Total 13F shares, excl. options
-
90.7M
-
Shares change
-
-1.8M
-
Total reported value, excl. options
-
$2.48B
-
Value change
-
-$47M
-
Put/Call ratio
-
0.34
-
Number of buys
-
127
-
Number of sells
-
-95
-
Price
-
$27.39
Significant Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q3 2024
272 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q3 2024.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 242 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 90.7M shares
of 93.1M outstanding shares and own 97.41% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (15.4M shares), VANGUARD GROUP INC (10.3M shares), WELLINGTON MANAGEMENT GROUP LLP (6.72M shares), MILLENNIUM MANAGEMENT LLC (5.18M shares), STATE STREET CORP (4.7M shares), EARNEST PARTNERS LLC (3.96M shares), Camber Capital Management LP (3.95M shares), BANK OF AMERICA CORP /DE/ (2.9M shares), DISCIPLINED GROWTH INVESTORS INC /MN (2.53M shares), and Artisan Partners Limited Partnership (2.43M shares).
This table shows the top 242 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.